View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
February 20, 2020

Study finds new SARS-like coronavirus spreads more like flu

A new study by Chinese researchers found that SARS-CoV-2, the new coronavirus, which is genetically similar to SARS, also a type of coronavirus, acts much more like influenza.


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates


Follow the latest updates of the outbreak on our timeline.

A study by Chinese researchers found that SARS-CoV-2, the coronavirus, genetically similar to SARS, also a type of coronavirus, acts more like influenza.

The findings, based on upper respiratory specimens from 18 patients in China, indicate that the virus may spread more easily than previously thought.

SARS-CoV was responsible for a global epidemic in 2002–2003, recording 8096 confirmed cases in more than 25 countries. The transmission of this virus took place after days of illness. It involved modest viral loads in the respiratory tract in early days, while viral loads peaked around ten days after symptom onset.

Meanwhile, SARS-CoV-2 led to more than 75,700 confirmed cases to date, and the epidemic is ongoing. The route of transmission is principally aerosol via respiratory droplets and direct contact.

During the study, the novel coronavirus was found in one asymptomatic patient, similar to symptomatic patients, confirming concerns that asymptomatic or minimally symptomatic patients could also spread the disease.

In the 17 symptomatic patients, virus levels increased immediately after symptoms initially appeared. A higher amount of virus was found in the nose compared to the throat.

Following analysis, the researchers concluded that the viral nucleic acid shedding pattern of SARS-CoV-2 patients is more similar to those with influenza than patients infected with SARS-CoV.

The researchers published their findings in the New England Journal of Medicine.

In a separate study, data from more than 44,000 confirmed Covid-19 cases showed that the virus is not as deadly as other coronaviruses.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology